Title | Author(s) | Issue date | ???itemlist.??? |
Bilateral papillary renal cell carcinoma | Gossios, K.; Argyropoulou, M.; Vazakas, P.; Stefanaki, S.; Stavropoulos, N. E. | 24-Nov-2015 | - |
A clinicopathological study of the expression of extracellular matrix components in urothelial carcinoma | Ioachim, E.; Michael, M.; Stavropoulos, N. E.; Kitsiou, E.; Salmas, M.; Malamou-Mitsi, V. | 24-Nov-2015 | - |
Endometrioid carcinoma of the prostate. The diagnostic value of Leu7 and prostatic specific antigen | Stavropoulos, N. E.; Ioackim-Velogianni, E.; Sidoni, K.; Stefanou, D.; Klouvas, G.; Pavlidis, N. | 24-Nov-2015 | - |
Hypoxia-inducible factors HIF-1alpha and HIF-2alpha expression in bladder cancer and their associations with other angiogenesis-related proteins | Ioachim, E.; Michael, M.; Salmas, M.; Michael, M. M.; Stavropoulos, N. E.; Malamou-Mitsi, V. | 24-Nov-2015 | - |
Immunohistochemical expression of retinoblastoma gene product (Rb), p53 protein, MDM2, c-erbB-2, HLA-DR and proliferation indices in human urinary bladder carcinoma | Ioachim, E.; Charchanti, A.; Stavropoulos, N. E.; Skopelitou, A.; Athanassiou, E.; Agnantis, N. J. | 24-Nov-2015 | - |
Immunohistochemical prognostic markers in bladder cancer | Ioachim, E.; Stavropoulos, N. E.; Charalabopoulos, K.; Agnantis, N. J. | 24-Nov-2015 | - |
Lipid peroxidation and the use of emulsified propofol in laparoscopic surgery | Manataki, A. D.; Tselepis, A. D.; Glantzounis, G. K.; Arnaoutoglou, H. M.; Tsimoyiannis, E. C.; Stavropoulos, N. E. | 24-Nov-2015 | - |
The lipophilic extract of Hypericum perforatum exerts significant cytotoxic activity against T24 and NBT-II urinary bladder tumor cells | Skalkos, D.; Stavropoulos, N. E.; Tsimaris, I.; Gioti, E.; Stalikas, C. D.; Nseyo, U. O.; Ioachim, E.; Agnantis, N. J. | 24-Nov-2015 | - |
Local immune response after intravesical interferon gamma in superficial bladder cancer | Stavropoulos, N. E.; Ioachim, E.; Pavlidis, N.; Pappa, L.; Kalomiris, P.; Agnantis, N. J. | 24-Nov-2015 | - |
Localization of metallothionein in urothelial carcinoma of the human urinary bladder: an immunohistochemical study including correlation with HLA-DR antigen, p53, and proliferation indices | Ioachim, E. E.; Charchanti, A. V.; Stavropoulos, N. E.; Athanassiou, E.; Michael, M. C.; Agnantis, N. J. | 24-Nov-2015 | - |
Lymphocyte subsets in superficial bladder cancer: correlation with biological activity of the tumours | Stavropoulos, N. E.; Ioachim, E.; Hastazeris, K.; Goussia, A.; Agnantis, N. J. | 24-Nov-2015 | - |
Prognostic significance of thymidine phosphorylase in superficial bladder carcinoma | Stavropoulos, N. E.; Bouropoulos, C.; Ioachim, E.; Michael, M.; Hastazeris, K.; Tsimaris, I.; Kalogeras, D.; Liamis, Z.; Kafarakis, V.; Stefanaki, S.; Malamou-Mitsi, V. | 24-Nov-2015 | - |
Radical therapy for muscle-infiltrating bladder cancer (cystectomy or radiotherapy): does age affect the final therapeutic benefit for the patient? | Kalogeras, D.; Lampri, E.; Goussia, A.; Bai, M.; Capizzello, A.; Tassiou, I.; Stavropoulos, N. E.; Tsekeris, P. | 24-Nov-2015 | - |
Thrombospondin-1 expression in urothelial carcinoma: prognostic significance and association with p53 alterations, tumour angiogenesis and extracellular matrix components | Ioachim, E.; Michael, M. C.; Salmas, M.; Damala, K.; Tsanou, E.; Michael, M. M.; Malamou-Mitsi, V.; Stavropoulos, N. E. | 24-Nov-2015 | - |
Tumor markers in stage P1 bladder cancer | Stavropoulos, N. E.; Ioachim, E.; Charchanti, A.; Michael, M. C.; Kitsiou, E.; Mihailidis, I.; Hastazeris, K.; Agnantis, N. J. | 24-Nov-2015 | - |